|
Re: open access editorial in JCO accompanies article which MAY show equivalence of
Lani-many thanks for such a comprehensive answer. It makes a lot of sense now.
In answer to the question about targeted treatments from unregistered my understanding is that there are a number of other targeted treatments in trials for example neratinib and pertuzumab.These hopefully will offer more less toxic treatments in the long term.
Ellie
|